Multimodal Imaging in Rectal Cancer & Pancreatic Cancer
Status:
UNKNOWN
Trial end date:
2025-06-02
Target enrollment:
Participant gender:
Summary
Most digestive cancers show (over)expression of the tumour marker carcinoembryonic antigen (CEA). Therefore, interest in CEA-targeting tracers has increased over the past years. CEA-targeting tracers can be used for preoperative, intra-operative and postoperative imaging purposes. This study focusses on both preoperative and intraoperative multimodal imaging and image-guided surgery in patients with rectal cancer or pancreatic cancer.